Imec is a world‑leading research and innovation center in nanoelectronics and digital technologies. As a pioneer in deeptech, imec brings the power of chip technology to the world of healthcare. Together with its partners in life sciences, medtech, pharma, and biotech, imec develops next‑generation technologies requiring extremely high sensitivity (down to the level of single‑molecule interactions to analyze DNA and gene expression), single‑cell manipulation, massive parallelization, miniaturization, and ultra‑low‑power operation. Imec combines extensive chip‑processing facilities, including 200‑mm and 300‑mm cleanrooms; state‑of‑the‑art bio‑lab infrastructure for surface and bioassay characterization, biosensor setups, and DNA research; and world‑renowned expertise in chip technology, MEMS, bioelectronics, sensors, photonics, imagers, microfluidics, biosciences, and high‑performance computing. Imec is headquartered in Leuven (Belgium) with research sites across the world. In 2024, imec’s revenue (P&L) totalled 1 billion euros.